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Heart failure (HF) is a chronic limiting disease associated with high
morbidity and mortality [1–2]. Several clinical and laboratory
variables have been recognized as associated with the prognosis,
morbidity and mortality of patients with heart failure, including
patients' ethnicity [3–4].
The evaluation of the association between self-declared skin color
with complex diseases, such as HF, may be challenging because of the
heterogeneity within ethnic groups, especially in countries like Brazil
where there is a large admixture. Thus, the estimated genomic ancestry
of a population or individual, with the use of autosomal ancestry
informative markers (AIMs) and mitochondrial haplogroups (mt-
haplogroups), may provide a more accurate prediction of the ethnic-
associated genetic risk factors that inﬂuence health and disease [5–7].
The aim of the present study was to examine the association
between genetic ancestry, estimated by autosomal ancestry informa-
tive markers and mitochondrial DNA (mtDNA), with the survival rate
of 503 patients with heart failure.
A cross-sectional study was performed in 503 patients with heart
failure from the Public Health System (SUS), belonging to the
healthcare program developed by the Heart Institute of the Medical
School, University of São Paulo. The patients were clinically followed
up for four years or until death or heart transplantation. The research
protocol was approved by the Ethics Committee of the Clinical
Hospital of the Medical School, University of São Paulo, and all
participants signed an informed consent.
The mtDNA analysis for the composition of haplotypes
(sequences) and mt-haplogroup classiﬁcation was realized in the
control region of mtDNA [8].
The mtDNA sequence data reported in this paper has been
deposited in the NCBI GenBank database under accession numbers:
KC676330–KC676585 and KC688421–KC688674.
The evaluation of genomic ancestry was conducted using 48
biallelic ancestry informative markers (AIMs) (16 markers of
African ancestry, 16 of European ancestry, and 16 of Amerindian
ancestry) type insertion–deletion (INDEL) from autosomal chro-
mosomes [8–9].
For establishing the association between mitochondrial hap-
logroups and survival, Kaplan–Meier curves were constructed and
compared through the log rank test. Cox's proportional hazards
regression model, Gehan–Breslow test and Tarone–Ware test were
used to evaluate the effect of independent predictors of patient
survival.
For genomic ancestry, association with survival was determined
using univariate and multivariate analysis, with the Cox proportional
hazards regression model. All statistical analyses were carried out
using SPSS software (version 16.0, IBM, New York, NY), with the level
of signiﬁcance set at p ≤ 0.05.
Of the 503 patients with heart failure evaluated in this study, the
mean age was 58 years (SD =±14.4 years) and the majority were
male (59.6%, n = 300). The majority of patients self-declared as white
(73.4%, n = 369), followed by brown (13.5%, n = 68) and black
(10.5%, n = 53).
The analysis of mtDNA showed that the African mt-haplogroups
were the most prevalent (n = 234, 46.4%) followed by Amerindian
(n = 142, 28.2%), and European mt-haplogroups (n = 127, 25.4%).
From the analysis of 48 INDELs, the major contribution of autosomal
genomic ancestrywas the European, 57.4% (±22.2%), followed by the
African, 28.4% (±21.7%) and fewer from the Amerindian, 14.1%
(±10%).
At the end of four years of evaluation, 50.3% (n = 253) of the
patients had died. Duration of follow-up of the patients from the time
of enrollment until death or last contact was 3.8 years (mean
1401 days, ±207 days).
The probability of survival of patients relative to autosomal
genomic ancestries showed higher survival for patients with a higher
contribution of Amerindian genomic ancestry (p = 0.004 [OR 0.13
{0.03–0.52}]), (Table 1). These data remained statistically signiﬁcant
after adjusting for age, sex, left ventricular ejection fraction, self-
declared ethnicity, cause of heart failure, and mt-haplogroups
(Table 2).
This ﬁnding is particularly relevant since the information about the
Amerindian genetic background is not usually retrieved by the
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Table 1
Prognosis of patients with heart failure relative to autosomal genomic ancestry.
Genomic ancestry p-Value Odds ratio (95% conﬁdence interval)
Amerindian 0.004 0.13 (0.03–0.52)
European 0.653 1.15 (0.63–2.10)
African 0.313 1.36 (0.75–2.48)
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standard self-referred questions about ethnicity [8]. In fact, for a
mixed population, such as the Brazilian, genetic determination of
autosomal ancestry may be the best technique to unveil this
characteristic associated with better prognosis.
Some recent studies, which also used AIMs, demonstrated/
suggested that the genomic Amerindian ancestry may be protective
against hypertension inwomen from the United States [10], protective
against metabolic syndrome in the population of Costa Rica [11] and
protective against Alzheimer's disease in Brazilian population [12].
Furthermore, recent studies in the Brazilian population showed that
Amerindian individuals had lesser arterial stiffness and hypertension
[13–14]. These studies suggest that lower risk of diseases studied in
individuals with Amerindian ancestry may be due to the existence of
protective genetic factors associated with this ancestry.
In conclusion, our study found that individuals with a higher
contribution of Amerindian ancestry had higher survival rates in
Brazilian patients with heart failure.Wewere not able to ﬁnd previous
reports of the main ﬁndings of our study. If such ﬁndings are
conﬁrmed, operativemechanisms deserve further research.We added
data to substantiate the hypothesis that differences in ethnic
backgrounds may be a signiﬁcant issue in epidemiological studies
andmay help to better understand complex diseases like heart failure.
There is no conﬂict of interest.
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Table 2
Variables associated with prognosis in patients with heart failure in relation to
Amerindian autosomal genomic ancestry.
Variables p-Value Odds ratio
Amerindian ancestry 0.003 0.09 (0.02–0.44)
Age 0.001 1.02 (1.01–1.77)
Sex 0.782 0.96 (0.71–1.29)
Ejection fraction 0.001 0.98 (0.97–0.99)
Self-declared ethnicity
White 0.195 1.15 (0.93–1.44)
Brown 0.540 1.07 (0.87–1.32)
Black 0.524 1.21 (0.67–2.20)
Etiology
Chagas' heart disease 0.099 0.22 (0.03–2.25)
Idiopathic 0.204 1.55 (0.79–3.07)
Hypertensive 0.655 0.84 (0.40–1.78)
Ischemic 0.308 0.71 (0.37–1.37)
Valvular 0.473 1.27 (0.66–2.41)
Other 0.311 1.41 (0.72–2.76)
mt-haplogroups
African 0.521 1.06 (0.89–1.27)
Amerindian 0.481 0.89 (0.63–1.24)
European 0.745 0.86 (0.34–2.17)
The bold data indicates the parameter with statistical signiﬁcancy.
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